Effectiveness of BBV152 vaccine and ChAdOx1-S vaccine in preventing severe disease among vaccinated patients admitted to a designated COVID-19 hospital in India.

Rajaraman Nivetha Ramesh Anshul Subbarayan Sarojini Chinnaian Sivagurunathan Chandrasekar Janaganbose Maikandaan

Published in: Clinical and experimental vaccine research (2024)

This study indicates that both vaccines were highly effective (90%) in preventing severe forms of the disease in fully vaccinated individuals. When comparing the two vaccines, BBV152 was slightly more effective than ChAdOx1-S in preventing severe COVID-19.

Keyphrases

coronavirus disease
sars cov
early onset
randomized controlled trial
healthcare
systematic review
emergency department
acute care